NCT03744741View on ClinicalTrials.gov

HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study

CompletedOBSERVATIONAL
Enrollment

585

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

November 25, 2019

Study Completion Date

January 20, 2020

Conditions
Respiratory Tract InfectionsUrinary Tract InfectionsSkin and Soft Tissue InfectionsIntraabdominal InfectionsSepsis
Interventions
DIAGNOSTIC_TEST

HostDx Sepsis

Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection

Trial Locations (7)

12462

Attikon University Hospital, Chaïdári

16148

University of Pittsburgh Medical Center, Pittsburgh

30322

Emory University, Atlanta

40536

University of Kentucky Chandler Medical Center, Lexington

48202

Henry Ford Hospital, Detroit

79905

Texas Tech University Health Sciences Center El Paso, El Paso

01199

Baystate Medical Center, Springfield

Sponsors

Lead Sponsor

Inflammatix
All Listed Sponsors
lead

Inflammatix

INDUSTRY